Skip to main content

Smartphone-Based Measures Can Help ID Frontotemporal Lobar Degeneration

Medically reviewed by Carmen Pope, BPharm. Last updated on April 1, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, April 1, 2024 -- Smartphone tests can accurately differentiate individuals with frontotemporal lobar degeneration (FTLD) from controls, according to a study published online April 1 in JAMA Network Open.

Adam M. Staffaroni, Ph.D., from the University of California in San Francisco, and colleagues examined the reliability and validity of smartphone-based cognitive measures for remote FTLD evaluations in a cohort study. During two weeks, controls and participants with FTLD performed smartphone application (app)-based executive functioning tasks and an associated memory task three times. A total of 360 participants were enrolled in the study and divided into discovery and validation cohorts (258 and 102 participants, respectively).

Smartphone tests showed moderate-to-excellent reliability in the participants. The researchers found that the association of smartphone tests with disease severity, criterion-standard neuropsychological tests, and brain volume supported the validity. Individuals with dementia were accurately differentiated from controls by smartphone tests (area under the curve [AUC], 0.93), which were more sensitive to early symptoms (AUC, 0.82) than the Montreal Cognitive Assessment (AUC, 0.68). Highly similar reliability and validity findings were seen in the discovery and validation cohorts. Compared with noncarrier family controls, preclinical participants who harbored pathogenic variants performed significantly worse on three app tasks, but not on a composite of traditional neuropsychological measures.

"The findings of this cohort study, coupled with prior reports indicating that smartphone testing is feasible and acceptable to patients with FTLD, suggest that smartphones may complement traditional in-person research paradigms," the authors write.

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Half of Native Americans Older Than 70 Years May Have Cognitive Impairment

FRIDAY, May 17, 2024 -- More than half of Native Americans aged 70 years and older have cognitive impairment, according to a study published online May 15 in Alzheimer's...

Individual Ability to Be Mobile in Community Tied to Cognitive Function

WEDNESDAY, May 15, 2024 -- Community mobility is significantly associated with cognitive function in older adults, according to a study published online May 15 in the Journal...

Higher Olive Oil Intake Tied to Lower Risk for Dementia-Related Death

WEDNESDAY, May 8, 2024 -- Higher olive oil intake is associated with a lower risk for dementia-related mortality in U.S. adults, according to a study published online May 6...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.